19 September 2024NewsUnified Patent CourtMarisa Woutersen

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

The founding partner of Bird & Bird’s Dutch office explores his recent victory for Edwards Lifesciences and his active role at the court.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Unified Patent Court

Regeneron and CureVac: UPC ‘cannot be ignored’

4 November 2025 Growing clout, powerful remedies, and efficiency are making the UPC a game-changer in global litigation, according to LSPN Europe experts. Tom Phillips reports.

Unified Patent Court

Abbott v Sibio: A game-changer for UPC tech disputes

27 February 2025 The UPC Court of Appeal’s approach to delivering a preliminary injunction in a glucose sensor dispute has far-reaching effects, as Wouter Pors of Bird & Bird explains.

Unified Patent Court

'A very good decision’: Patent industry welcomes UPC in-house reps update

13 February 2025 Court of Appeal says in-house representatives can appear before the court | Patent attorneys with ‘administrative and financial powers’ or shares remain barred | Decision specific to Microsoft v Suinno Mobile & AI Technologies Licensing.

More features

Baker McKenzie strengthens IP bench with new German lead

Cancer drug researcher hit with suit over mutation-targeting tools

Novo Nordisk and OpenAI strike AI deal to boost drug discovery

Court narrows Mylan’s Copaxone suit but key claims survive

IP finance gap risks startup exodus, EUIPO warns

Oracle retaliates with lawsuit to laid-off staff member’s ‘demands’

Patent office fee increases: What applicants must know

LSPN Awards USA: Meet the judges

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

More on this story

Editor's picks

Editor's picks

More features